News
Our newsfeed is undergoing a system update. All stories will be repopulated soon!
-
#ESMO25: Neoadjuvant T-DXd Combo Tops Anthracycline Standard With Less Toxicity in HER2+ eBC
At the 2025 European Society for Medical Oncology (ESMO) Congress, Nadia Harbeck,…
-
#WCLC25: Four-Year Median OS with Osimertinib/ Chemotherapy Combination in Advanced EGFR-Mutation Positive NSCLC
The final overall survival (OS) analysis from the FLAURA2 trial was presented…
Newsletter Coming Soon!
Beginning in 2026, we will be sending out a quarterly newsletter on key oncology insights and updates.